ArticleGene therapy2018

HIV-based lentivirus-mediated vasoactive intestinal peptide gene delivery protects against DIO animal model of Type 2 diabetes.

Hale M Tasyurek et al.PubMed ↗Publisher ↗

No numbers read from the abstract.